Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Targeted radiotherapy for early breast cancer - Authors' reply.

Coles CE, Haviland JS, Kirby AM, Titley J, Wilcox M, Bliss JM, Yarnold JR.

Lancet. 2018 Jan 6;391(10115):27-28. doi: 10.1016/S0140-6736(17)33317-2. No abstract available.

PMID:
29323651
2.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

3.

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

Tsang Y, Ciurlionis L, Kirby AM, Locke I, Venables K, Yarnold JR, Titley J, Bliss J, Coles CE; IMPORT Trial Management Group.

Br J Radiol. 2015;88(1056):20150453. doi: 10.1259/bjr.20150453. Epub 2015 Oct 22.

4.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique.

Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM; on behalf of the IMPORT Trials Management Group.

Southampton (UK): NIHR Journals Library; 2014 Nov.

5.

The IMPORT HIGH image-guided radiotherapy study: a model for assessing image-guided radiotherapy.

Donovan EM, Harris EJ, Mukesh MB, Haviland JS, Titley J, Griffin C, Coles CE, Evans PM; IMPORT Trials Management Group.

Clin Oncol (R Coll Radiol). 2015 Jan;27(1):3-5. doi: 10.1016/j.clon.2014.09.012. Epub 2014 Oct 16. No abstract available.

PMID:
25445551
6.

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.

Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, Dennis J, Tyrer JP, Wilkinson JS, Gómez-Caamaño A, Tanteles GA, Platte R, Mayes R, Conroy D, Maranian M, Luccarini C, Gulliford SL, Sydes MR, Hall E, Haviland J, Misra V, Titley J, Bentzen SM, Pharoah PD, Burnet NG, Dunning AM, West CM.

Radiother Oncol. 2014 May;111(2):178-85. doi: 10.1016/j.radonc.2014.02.012. Epub 2014 Apr 28.

PMID:
24785509
7.

Prospective observational cohort study of Health Related Quality of Life (HRQOL), chronic foot problems and their determinants in gout: a research protocol.

Chandratre P, Mallen C, Richardson J, Rome K, Bailey J, Gill R, Hider S, Mason J, Mayson Z, Muller S, Purcell C, Titley J, Wathall S, Zwierska I, Roddy E.

BMC Musculoskelet Disord. 2012 Nov 13;13:219. doi: 10.1186/1471-2474-13-219.

8.

Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada.

Kundhal KK, Chin SL, Harrison L, Nowacki B, Doobay B, Titley J, Ciná C, Anand SS.

Can J Cardiol. 2007 Apr;23(5):357-61.

9.

Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma.

Wang R, Titley JC, Lu YJ, Summersgill BM, Bridge JA, Fisher C, Shipley J.

Mod Pathol. 2003 Aug;16(8):778-85.

10.
11.

Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: a feasibility study.

Coley HM, Sargent JM, Williamson CJ, Titley J, Scheper RJ, Gregson SE, Elgie AW, Lewandowicz GM, Taylor CG.

Anticancer Res. 2002 Jan-Feb;22(1A):69-74.

PMID:
12017336
12.

Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells.

Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM.

Br J Cancer. 2002 Mar 18;86(6):963-70.

13.

Unique case of fatal carbon monoxide poisoning in the absence of a combustible fossil fuel.

Morgan DR, Poon P, Titley J, Jagger SF, Rutty GN.

Am J Forensic Med Pathol. 2001 Sep;22(3):220-4.

PMID:
11563726
14.
15.

Comparison of thymidylate synthase (TS) protein up-regulation after exposure to TS inhibitors in normal and tumor cell lines and tissues.

Welsh SJ, Titley J, Brunton L, Valenti M, Monaghan P, Jackman AL, Aherne GW.

Clin Cancer Res. 2000 Jun;6(6):2538-46.

16.

Deoxyglucose uptake by a head and neck squamous carcinoma: influence of changes in proliferative fraction.

Smith TA, Titley J.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):219-23.

PMID:
10758327
17.

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI.

Mol Pharmacol. 2000 Mar;57(3):503-11.

PMID:
10692490
18.

Differentiation of separated mouse mammary luminal epithelial and myoepithelial cells cultured on EHS matrix analyzed by indirect immunofluorescence of cytoskeletal antigens.

Smalley MJ, Titley J, Paterson H, Perusinghe N, Clarke C, O'Hare MJ.

J Histochem Cytochem. 1999 Dec;47(12):1513-24.

PMID:
10567435
19.

Lack of prognostic significance of ploidy and S-phase measurements in advanced ovarian cancer.

Coley HM, Sargent JM, Titley J, Taylor CG.

Anticancer Res. 1999 May-Jun;19(3A):2111-6.

PMID:
10470157
20.
21.

Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis.

Ronen SM, DiStefano F, McCoy CL, Robertson D, Smith TA, Al-Saffar NM, Titley J, Cunningham DC, Griffiths JR, Leach MO, Clarke PA.

Br J Cancer. 1999 Jun;80(7):1035-41.

22.

A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus.

Skelton LA, Ormerod MG, Titley J, Kimbell R, Brunton LA, Jackman AL.

Br J Cancer. 1999 Apr;79(11-12):1692-701.

23.

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study.

Makris A, Powles TJ, Allred DC, Ashley SE, Trott PA, Ormerod MG, Titley JC, Dowsett M.

Breast Cancer Res Treat. 1999 Jan;53(1):51-9.

PMID:
10206072
24.

Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells.

Kamalati T, Davies D, Titley J, Crompton MR.

Clin Exp Metastasis. 1998 Jul;16(5):415-26.

PMID:
10091937
25.
27.
28.
29.

Analysis and sorting of apoptotic cells from fine-needle aspirates of excised human primary breast carcinomas.

Dowsett M, Detre S, Ormerod MG, Ellis PA, Mainwaring PN, Titley JC, Smith IE.

Cytometry. 1998 Aug 1;32(4):291-300.

PMID:
9701398
30.

Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response.

Makris A, Powles TJ, Allred DC, Ashley S, Ormerod MG, Titley JC, Dowsett M.

Breast Cancer Res Treat. 1998 Mar;48(1):11-20.

PMID:
9541185
31.

An unusual artefact in the terminal deoxynucleotidyl transferase assay for apoptotic cells.

Detre S, Ormerod MG, Titley JC, Dowsett M.

Cytometry. 1997 Jul 1;28(3):264-7.

PMID:
9222112
32.

Cytological evaluation of biological prognostic markers from primary breast carcinomas.

Makris A, Allred DC, Powles TJ, Dowsett M, Fernando IN, Trott PA, Ashley SE, Ormerod MG, Titley JC, Osborne CK.

Breast Cancer Res Treat. 1997 May;44(1):65-74.

PMID:
9164679
33.

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

Makris A, Powles TJ, Dowsett M, Osborne CK, Trott PA, Fernando IN, Ashley SE, Ormerod MG, Titley JC, Gregory RK, Allred DC.

Clin Cancer Res. 1997 Apr;3(4):593-600.

34.

The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.

Ormerod MG, Orr RM, O'Neill CF, Chwalinski T, Titley JC, Kelland LR, Harrap KR.

Br J Cancer. 1996 Dec;74(12):1935-43.

35.

Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.

O'Neill CF, Ormerod MG, Robertson D, Titley JC, Cumber-Walsweer Y, Kelland LR.

Br J Cancer. 1996 Oct;74(7):1037-45.

36.

Interleukin-4 enhances the survival of severe combined immunodeficient mice engrafted with human B-cell precursor leukemia.

Mitchell PL, Clutterbuck RD, Powles RL, De Lord C, Morilla R, Hiorns LR, Titley J, Catovsky D, Millar JL.

Blood. 1996 Jun 1;87(11):4797-803.

PMID:
8639851
37.

Phosphocholine and choline content of rat sarcoma cells grown in the presence and absence of serum.

Smith TA, Eccles S, Box G, Titley JC, Leach MO, McCready VR.

Anticancer Res. 1996 May-Jun;16(3B):1389-92.

PMID:
8694506
38.

Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Ellis PA, Makris A, Burton SA, Titley J, Ormerod MG, Salter J, Powles TJ, Smith IE, Dowsett M.

Br J Cancer. 1996 Mar;73(5):640-3.

39.

Application of a bromodeoxyuridine-Hoechst/ethidium bromide technique for the analysis of radiation-induced cell cycle delays in asynchronous cell populations.

Gilligan D, Mort C, McMillan TJ, Peacock JH, Titley J, Ormerod MG.

Int J Radiat Biol. 1996 Feb;69(2):251-7.

PMID:
8609462
40.

Use of light scatter when recording a DNA histogram from paraffin-embedded tissue.

Ormerod MG, Titley JC, Imrie PR.

Cytometry. 1995 Nov 1;21(3):294-9.

41.

Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry.

Fernando IN, Powles TJ, Dowsett M, Ashley S, McRobert L, Titley J, Ormerod MG, Sacks N, Nicolson MC, Nash A, et al.

Virchows Arch. 1995;426(2):155-61.

PMID:
7757286
42.

Programmed cell death in response to chemotherapeutic agents in human germ cell tumour lines.

Huddart RA, Titley J, Robertson D, Williams GT, Horwich A, Cooper CS.

Eur J Cancer. 1995;31A(5):739-46.

PMID:
7640048
43.

Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.

Fernando IN, Titley JC, Powles TJ, Dowsett M, Trott PA, Ashley SE, Ford HT, Ormerod MG.

Br J Cancer. 1994 Dec;70(6):1211-6.

44.

Growth of primary human acute lymphoblastic and myeloblastic leukemia in SCID mice.

De Lord C, Clutterbuck R, Powles R, Morilla R, Hanby A, Titley J, Min T, Millar J.

Leuk Lymphoma. 1994 Dec;16(1-2):157-65.

PMID:
7696922
45.

Ectoenzyme regulation by phenotypically distinct fibroblast sub-populations isolated from the human mammary gland.

Atherton AJ, O'Hare MJ, Buluwela L, Titley J, Monaghan P, Paterson HF, Warburton MJ, Gusterson BA.

J Cell Sci. 1994 Oct;107 ( Pt 10):2931-9.

46.
47.
48.

Phospholipid metabolites, prognosis and proliferation in human breast carcinoma.

Smith TA, Bush C, Jameson C, Titley JC, Leach MO, Wilman DE, McCready VR.

NMR Biomed. 1993 Sep-Oct;6(5):318-23.

PMID:
8268064
49.

Cell-cycle progression during continuous low dose rate irradiation of a human bladder carcinoma cell line.

Skladowski K, McMillan TJ, Peacock J, Titley J, Steel GG.

Radiother Oncol. 1993 Sep;28(3):219-27.

PMID:
8255999
50.

Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy.

De Lord C, Clutterbuck RD, Powles RL, Min T, Titley JC, Millar JL.

Exp Hematol. 1993 Jun;21(6):826-8.

PMID:
8500581

Supplemental Content

Loading ...
Support Center